Actavis’ $70.5 billion purchase of Allergan set new mark for price.
A session on LASIK looked at the satisfaction rate of doctors who had the procedure at the Cleveland Clinic.
Novartis said it will invest $200 million in its eye care division.
The privately held company is developing the CyPass Micro-Stent to treat glaucoma.
FDA’s Malvina Eydelman said future approval process will include parameter for evaluating patient perspective.
Market Scope partnered with the Glaucoma Research Foundation to develop a custom survey for the meeting, which was held in January in San Francisco.
In an early stage clinical trial, the treatment cleared away fatty deposits behind the retina, leading to slight visual improvement in 10 of 23 patients.
Hearing looked at recent spikes in pricing that made huge profits for drugmakers.
The longtime CEO and chairman of the multinational drug company has been on medical leave since Dec. 28
Facility currently manufactures Restasis and Latisse.
Bill Meury will oversee Allergan’s ophthalmology and aesthetics businesses.
Newly opened hospitals failed to make enough money to pay debts incurred to open them.
Total was about half the record set in 2014.
The first automated capsulotomy device received CE marking.
The FDA backed new formulations of mature drugs, new indications, and generics.
Roche will reintroduce a security code to its vials, society says.
Shire’s application now includes data from five randomized controlled clinical trials.
The market is expected to grow to $2.7 billion by 2021, partly due to the impact of newer retinal implant devices.
The global market for surgical instruments is expected to exceed $1.14 billion in 2016.
Two large shareholders have committed a combined $12.8 million toward the investment round.
In a study of Western Australian twins, high vitamin D levels were associated with lower myopia.
The question on business plans is new to the survey. Fourth-quarter results were published Feb. 15.
After four years, a comparison of the long-term MRI and OCT results showed the rate of tissue thinning seen on OCT mirrored overall brain degeneration.
The two online companies are trying to change the way Americans buy drugs by quoting the lowest prices for generic prescriptions to allow comparison shopping.
The Fort Worth, Texas, company plans to release results in Q2-2016.
He was honored in 2012 by the Association for Research in Vision and Ophthalmology’s Foundation for Eye Research for his body of work.
You are not currently logged in.
©2017 Market Scope
Lost your Password